NEW YORK–(BUSINESS WIRE)–#RazomForUkraine–Razom (which means “together” in Ukrainian), a 501(c)3 non-profit organization dedicated to building a more prosperous Ukraine, has announced four mission trips to Ukraine taking place this spring as part of its Co-Pilot Project. Razom Co-Pilot Project’s mission is to address the significant deficit in high-quality neurosurgical, spine, reconstructive, and plastic surgery training … [Read more…]

SYDNEY–(BUSINESS WIRE)–Cybermindz, a groundbreaking not-for-profit organization dedicated to improving the mental health and well-being of cybersecurity professionals, will make its United States debut at the first-ever Mental Health in Cybersecurity Leadership Summit on April 24th at The Contemporary Jewish Museum in San Francisco. RSA Conference 2023, a globally recognized event for the cybersecurity industry, will … [Read more…]

Publications highlight the safety and tolerability of Radspherin® for patients and those externally exposed to radiation, all dose levels were well tolerated with dose level toxicity (DLT) not reached. OSLO–(BUSINESS WIRE)–Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced the online publication of two articles in … [Read more…]

HAMBURG, Germany–(BUSINESS WIRE)–#ai–In a first of its kind comparative study, Mindpeak’s CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g. Visiopharm). Mindpeak’s AI showed the highest accuracy of all AIs in terms of balanced clinical scores (88.1%) for HER2-low, higher than the score of the next best AI (67.3%) … [Read more…]

Study strongly supports Bio-RFID technology’s application in non-invasive bio-monitoring SEATTLE–(BUSINESS WIRE)–Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the results of a proof-of-principle study titled, “Detecting Unique Analyte-Specific Radio Frequency Spectral Responses in Liquid Solutions – Implications for Non-Invasive Physiologic Monitoring,” conducted in collaboration with Mayo Clinic. … [Read more…]

The data from the pivotal ECLIPSE Study accepted as a late-breaking abstract highlights the performance of the Shield™ blood test in detecting colorectal cancer in asymptomatic patients PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, is pleased to announce that it will present data from two studies highlighting the performance … [Read more…]

TAIPEI, Taiwan–(BUSINESS WIRE)–PharmaEssentia Corporation (TPEx:6446, LuxSE: PHECA, PHECR), a leading fully integrated biopharmaceutical company in Taiwan, today announced the closing of its Global Depositary Receipt (GDR) offering of 34,000,000 shares of common stock at US$13.61 per share, generating US$462.7 million. “This marks the largest global health care GDR offering to date in 2023 and reflects … [Read more…]

Chief Medical Officer Michael W. Belin, MD, will be a plenary speaker at the event SHERBORN, Mass.–(BUSINESS WIRE)–CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, announced today that CMO Michael W. Belin, MD, will present the Plenary Session at the 1st Annual International Keratoconus Academy (IKA) Symposium. The symposium will be … [Read more…]

HYDERABAD, India–(BUSINESS WIRE)–$RDY #DRREDDY–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent generic version of Remodulin® (treprostinil) Injection, approved by U. S. Food and Drug Administration (USFDA). Dr. … [Read more…]

MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will report first quarter 2023 financial results on Thursday, May 4, … [Read more…]